Does AMINOPHYLLINE Cause Product dose omission issue? 90 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Product dose omission issue have been filed in association with AMINOPHYLLINE (Aminophylline). This represents 10.8% of all adverse event reports for AMINOPHYLLINE.
90
Reports of Product dose omission issue with AMINOPHYLLINE
10.8%
of all AMINOPHYLLINE reports
33
Deaths
86
Hospitalizations
How Dangerous Is Product dose omission issue From AMINOPHYLLINE?
Of the 90 reports, 33 (36.7%) resulted in death, 86 (95.6%) required hospitalization, and 31 (34.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for AMINOPHYLLINE. However, 90 reports have been filed with the FAERS database.
What Other Side Effects Does AMINOPHYLLINE Cause?
Dyspnoea (269)
Asthma (260)
Vomiting (248)
Drug hypersensitivity (232)
Pneumonia (225)
Oedema (218)
Wheezing (208)
Off label use (134)
Pain (129)
Drug ineffective (123)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which AMINOPHYLLINE Alternatives Have Lower Product dose omission issue Risk?
AMINOPHYLLINE vs AMINOSALICYLATE
AMINOPHYLLINE vs AMINOSALICYLIC ACID
AMINOPHYLLINE vs AMIODARONE
AMINOPHYLLINE vs AMISULPRIDE
AMINOPHYLLINE vs AMITRIPTYLINE